RECIST criteria are inadequate for measuring ... For this reason, The Prostate Cancer Clinical Trials Working Group has defined radiological progression as the development of two or more lesions ...

The deal sees Endocyte acquire an exclusive worldwide licence for ABX’s phase 3-ready prostate cancer candidate 177Lu ... in 40% to 60% of patients, and a RECIST response rate in soft tissue ...

It’s tough for a man to know what to do following a diagnosis of prostate cancer.The treatment is often worse than the ...

The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new study.

Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancerscreeningis highly accurate. The exciting new results, published in The Journal ...

Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancer screening is highly accurate.

(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...

A recent study finds that genetically predicted rheumatoid arthritis is causally associated with prostate cancer.

A new study from UCSF reveals an “alarming” rise in advanced prostate cancer rates across California. The findings, published ...

Northwell Staten Island University Hospital has announced the addition of the Focal One High-Intensity Focused Ultrasound ...

A new urine test, MyProstateScore 2.0 (MPS2), can now detect aggressive prostate cancer with 94 per cent accuracy—no hospital ...

A study found a potential causal link between rheumatoid arthritis and increased prostate cancer risk. Researchers used ...